Population PK
Don't be afraid! Population PK-PD modeling as the basis for individualized dosing in children and critically ill
155
The role of population PK-PD modelling in paediatric clinical research
12
Mechanism-based model characterizing bidirectional interaction between PEGylated liposomal CKD-602 (S-CKD602) and monocytes in cancer patients
10
<p>Population pharmacokinetic analysis of tramadol and <em>O</em>-desmethyltramadol with genetic polymorphism of <em>CYP2D6</em></p>
11
Pharmacokinetic and exploratory exposure-response analysis of pertuzumab in patients with operable HER2-positive early breast cancer in the APHINITY study
12
Predicting tacrolimus concentrations in children receiving a heart transplant using a population pharmacokinetic model
8
Predicting the serum digoxin concentrations of infants in the neonatal intensive care unit through an artificial neural network
11
Population Pharmacokinetics of Alemtuzumab (Campath) in Pediatric Hematopoietic Cell Transplantation: Towards Individualized Dosing to Improve Outcome
12
Pooled post hoc analysis of population pharmacokinetics of oxycodone and acetaminophen following a single oral dose of biphasic immediate-release/extended-release oxycodone/acetaminophen tablets
11
CYP2B6*6, CYP2B6*18, Body weight and sex are predictors of efavirenz pharmacokinetics and treatment response: population pharmacokinetic modeling in an HIV/AIDS and TB cohort in Zimbabwe
10
Standard PK/PD concepts can be applied to determine a dosage regimen for a macrolide: the case of tulathromycin in the calf
40
On testing global optimization algorithms for space trajectory design
25
Exploring population pharmacokinetic models in patients treated with vancomycin during continuous venovenous hemodiafiltration on different anticoagulant modalities
149
Population Pharmacokinetic/Pharmacodynamic Analysis of Nociceptive Pain Models Following an Oral Pregabalin Dose Administration to Healthy Subjects
8
Pharmacokinetics and safety of ixazomib plus lenalidomide–dexamethasone in Asian patients with relapsed/refractory myeloma: a phase 1 study
9
Selective use of sorafenib in the treatment of thyroid cancer
13
On (p1,…,pk)-spherical distributions
18
PubMedCentral-PMC5177463.pdf
32
DNA-PK Deficiency in Alzheimer's Disease
6
Observation of the Decay Ξb- →pK-K-
11